Oncolytic Viruses Get a Boost With First FDA-approval Recommendation

Nature Reviews Drug Discovery - United Kingdom
doi 10.1038/nrd4680
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC